BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc., reported a 76% month-over-month revenue increase for its recently acquired operating subsidiary, VerdaGenix LLC d/b/a Ancient Extracts USA, according to a preliminary review of May 2026 operating results. The company noted that operations commenced under UNLOCKD ownership during the middle of May following the acquisition closing, meaning the reported May revenue reflects only a partial month of operations.
Preliminary April 2026 revenue was approximately $12,670, while preliminary May 2026 revenue increased to approximately $22,344. Additionally, on June 2, 2026, Ancient Extracts received a purchase order representing approximately $58,823 in retail product value, with an order total of approximately $29,411 under wholesale pricing terms. All financial figures are preliminary, unaudited, and subject to further review.
“We remain in the early stages of integrating Ancient Extracts into the UNLOCKD organization, but we are encouraged by the commercial momentum we are seeing,” stated John P. Gorst, Chief Executive Officer of UNLOCKD. “The combination of accelerating revenue, customer demand, and expanding distribution opportunities reinforces our belief that Ancient Extracts possesses many of the qualities that originally attracted us to this acquisition.”
Ancient Extracts USA offers a growing portfolio of functional mushroom products, ceremonial teas, cacao blends, matcha products, shilajit, and wellness-focused consumer goods marketed under the brand philosophy of “Ancient Remedies for Modern Life.” The company believes the brand is well positioned to benefit from growing consumer interest in functional mushrooms, adaptogens, botanical wellness products, and evidence-informed approaches to health and human performance.
Dr. Jordan P. Balencic, Chairman and Chief Science Officer of UNLOCKD, commented: “When we evaluated Ancient Extracts, we believed the business possessed a number of attractive characteristics, including a differentiated product portfolio, a loyal customer base, a capital-efficient operating model, and multiple pathways for future growth. While it remains early in the integration process, the initial operating results and commercial traction we are seeing continue to reinforce our conviction in the opportunity.”
Separately, the company announced that its UNLOCKD Technologies division has begun preliminary planning activities related to future consumer health technology opportunities, including early-stage evaluation of point-of-care testing concepts and preliminary discussions with developers, suppliers, and potential strategic partners. These initiatives remain in the conceptual and planning stages, and the company expects any future technology development efforts to follow a disciplined, milestone-driven approach, with dedicated financing rather than capital intended for current operating activities.
For more information, visit www.unlockdinc.com and follow @BFCHco on X for verified company updates. View the original release on www.newmediawire.com.
